Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia

Susie Hu; Gregory C. Shearer; Michael W. Steffes; William S. Harris; Andrew G. Bostom

doi:10.1053/j.ajkd.2010.06.029

Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia

Susie Hu
, Gregory C. Shearer
, Michael W. Steffes
, William S. Harris
, Andrew G. Bostom

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	181-182
Number of pages	2
Journal	American Journal of Kidney Diseases
Volume	57
Issue number	1
DOIs	https://doi.org/10.1053/j.ajkd.2010.06.029
State	Published - Jan 2011

All Science Journal Classification (ASJC) codes

Nephrology

Access to Document

10.1053/j.ajkd.2010.06.029

Cite this

@article{5a6e34a73ff444a685ad0bf04f3cef71,

title = "Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia",

author = "Susie Hu and Shearer, \{Gregory C.\} and Steffes, \{Michael W.\} and Harris, \{William S.\} and Bostom, \{Andrew G.\}",

note = "Funding Information: Support: Funding for the phosphorus assays was provided by a grant to Dr Hu from the Brown University Foundation for Health , project no. 8791 . The parent study, Niacin, n-3 Fatty Acids and Insulin Resistance ( ClinicalTrials.gov registration no. NCT00286234 ), was funded through a National Institute of Diabetes and Digestive and Kidney Diseases grant to Dr Harris. Placebos and pharmaceuticals were provided by Abbott Laboratories and GlaxoSmithKline. Dr Shearer receives research support from GlaxoSmithKline . ",

year = "2011",

month = jan,

doi = "10.1053/j.ajkd.2010.06.029",

language = "English (US)",

volume = "57",

pages = "181--182",

journal = "American Journal of Kidney Diseases",

issn = "0272-6386",

publisher = "W.B. Saunders",

number = "1",

}

TY - JOUR

T1 - Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia

AU - Hu, Susie

AU - Shearer, Gregory C.

AU - Steffes, Michael W.

AU - Harris, William S.

AU - Bostom, Andrew G.

N1 - Funding Information: Support: Funding for the phosphorus assays was provided by a grant to Dr Hu from the Brown University Foundation for Health , project no. 8791 . The parent study, Niacin, n-3 Fatty Acids and Insulin Resistance ( ClinicalTrials.gov registration no. NCT00286234 ), was funded through a National Institute of Diabetes and Digestive and Kidney Diseases grant to Dr Harris. Placebos and pharmaceuticals were provided by Abbott Laboratories and GlaxoSmithKline. Dr Shearer receives research support from GlaxoSmithKline .

PY - 2011/1

Y1 - 2011/1

UR - https://www.scopus.com/pages/publications/78650521671

UR - https://www.scopus.com/pages/publications/78650521671#tab=citedBy

U2 - 10.1053/j.ajkd.2010.06.029

DO - 10.1053/j.ajkd.2010.06.029

M3 - Letter

C2 - 20888102

AN - SCOPUS:78650521671

SN - 0272-6386

VL - 57

SP - 181

EP - 182

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

IS - 1

ER -

Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this